Christopher Ellstrom, MD
Plastic and Reconstructive Surgery · Newport Beach, CANPI 1578853750
Payments from drug & device makers
Across 78 payments — averaging $40.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TELA Bio, Inc.$886
- Mentor Worldwide LLC$482
- Sientra, Inc.$300
- AbbVie$265
- Galderma Laboratories, L.p.$183
- Incyte Corporation$143
- plus $926 from 21 others
What the payments were for
- Food & beverage$3,185100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TELA Bio, Inc. | 9 | $886 |
| Mentor Worldwide LLC | 7 | $482 |
| Sientra, Inc. | 3 | $300 |
| AbbVie(2 entities) | 3 | $265 |
| Galderma Laboratories, L.p. | 10 | $183 |
| Incyte Corporation | 6 | $143 |
| Sun Pharmaceutical Industries Inc. | 6 | $127 |
| Regeneron Healthcare Solutions, Inc. | 4 | $108 |
| Davol Inc. | 2 | $100 |
| Biofrontera Inc. | 6 | $96 |
| DUSA Pharmaceuticals, Inc. | 3 | $64 |
| LEO Pharma Inc. | 2 | $56 |
| Bard Peripheral Vascular, Inc. | 2 | $42 |
| VYNE Pharmaceuticals Inc. | 1 | $39 |
| Lilly USA, LLC | 2 | $36 |
| Apyx Medical Corporation | 1 | $28 |
| Revance Therapeutics, Inc. | 1 | $26 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Merz North America, Inc. | 1 | $24 |
| Mayne Pharma Commercial LLC | 1 | $24 |
| Almirall LLC | 1 | $22 |
| Dermira, Inc. | 1 | $21 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $21 |
| Bristol Myers Squibb | 1 | $20 |
| Johnson & Johnson | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,185 in reported general payments places this provider in the 60th percentile of 349 plastic and reconstructive surgery providers in California.
See all plastic and reconstructive surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 13 | $119 |
| Doxycycline Hyclate | 12 | $107 |
| Gabapentin | 21 | $104 |
| Tramadol Hcl | 12 | $35 |
| Ondansetron Hcl | 11 | $35 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Newport Beach
- Hisham SeifyNewport Beach$215K
- Christina PrendergastNewport Beach$27K
- Lavinia ChongNewport Beach$12K
- Shankar LakshmanPasadena$3.5M
- Corey MaasSan Francisco$1.5M
- Anne WallaceSan Diego$896K
- David KulberLos Angeles$340K
- Mark SuskiThousand Oaks$294K
- Arian MowlaviLaguna Beach$250K
- Gregory BunckeSan Francisco$212K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.